Antiepileptic drug agent | Presumed mechanism of action |
---|---|
Brivaracetam | SV2A modulation |
Carbamazepine | Na+Â channel blockade |
Clobazam | GABA potentiation |
Clonazapam | GABA potentiation |
Diazepam | GABA potentiation |
Fosphenytoin/phenytoin | Na+Â channel blockade |
Lacosamide | Enhanced slow inactivation of voltage-gated Na+Â channels |
Lamotrigine | Na+Â channel blockade |
Levetiracetam | SV2A modulation |
Lorazepam | GABA potentiation |
Midazolam | GABA potentiation |
Oxcarbazepine | Na+Â channel blockade |
Pentobarbital | GABA potentiation |
Perampanel | AMPA glutamate receptor antagonist |
Phenobarbital | GABA potentiation |
Topiramate | Na+Â channel blockade, GABA potentiation, AMPA/Kainate glutamate antagonist |
Valproic acid | GABA potentiation, glutamate (NMDA) inhibition, sodium channel and T-type calcium channel blockade |
Zonisamide | Na+Â and Ca2+ channel blockade |